Cleared Traditional

K093977 - ALLIGATOR-HD RETRIEVAL DEVICE (ARD-HD), MODEL FA-88840-XX

K093977 is an FDA 510(k) clearance for ALLIGATOR-HD RETRIEVAL DEVICE (ARD-HD), manufactured by Chestnut Medical Technologies, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 119-day FDA review.

K093977 · Chestnut Medical Technologies, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2010
Decision
119d
Days
Class 2
Risk

K093977 is an FDA 510(k) clearance for the ALLIGATOR-HD RETRIEVAL DEVICE (ARD-HD), MODEL FA-88840-XX. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Chestnut Medical Technologies, Inc. (Menlo Park, US). The FDA issued a Cleared decision on April 22, 2010 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Chestnut Medical Technologies, Inc. devices

FDA 510(k) Submission Details - K093977

510(k) Number K093977 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 24, 2009
Decision Date April 22, 2010
Days to Decision 119 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 125d · This submission: 119d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 669
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K093977.
SCOUTPRO HEMOSTATIC VALVE
K101282 · Biotronik, Inc. · Jul 2010
LEV-OR DILATION CATHETER OTW
K101117 · Baylis Medical Co., Inc. · Jul 2010
PENUMBRA CATHERER 025
K100826 · Penumbra, Inc. · Jul 2010
CLEARWAY OTW MODEL 85912
K093431 · Atrium Medical Corp. · Apr 2010
ACUITY BREAK-AWAY GUIDE CATHETER
K093969 · Cardiac Pacemakers, Inc. · Mar 2010
ASAHI ZENYTEEX GUIDING CATHETER
K091188 · Asahi Intecc Co., Ltd. · Feb 2010